1 year return (CAGR)
-57.57%
PharmaCyte Biotech Inc Exchange (NASDAQ, USD)
PMCB
0.43
-0.03 (-6.54%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-43.85%
5 year return (CAGR)
-35.87%
10 year return (CAGR)
-38.52%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
4.60M
Price/Sales
-
Ent value
-2.23M
Price/Book
0.13
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-7.93%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
306.07%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.44 |
| Daily high | 0.45 |
| Daily low | 0.42 |
| Daily Volume | 241K |
| All-time high | 1080.00 |
| 1y analyst estimate | - |
| Beta | 0.66 |
| EPS (TTM) | -1.82 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 17 Mar 2026 |
Downside potential
Loading...
Downside potential data
| PMCB | S&P500 | |
| Current price drop from All-time high | -99.96% | -1.29% |
| Highest price drop | -99.96% | -56.47% |
| Date of highest drop | 15 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -84.68% | -10.68% |
| Avg time to new high | 385 days | 12 days |
| Max time to new high | 5615 days | 1805 days |
News
